Regional Nuclear Pharmaceuticals

Regional Nuclear Pharmaceuticals (RNP) was a specialized provider of radiopharmaceutical products and services, primarily focused on the preparation and distribution of unit-dose radiopharmaceuticals for diagnostic imaging and therapeutic use. The company operated a network of radiopharmacies that served hospitals and clinics, ensuring the timely delivery of short-lived isotopes used in PET and SPECT imaging. RNP's core business revolved around the compounding of radiopharmaceuticals for oncology, cardiology, and neurology applications. The company was eventually acquired by Triad Isotopes, which was later integrated into Jubilant Radiopharma, consolidating its infrastructure into one of the largest radiopharmaceutical networks in the United States.